The U.S. Court of Appeals for the Federal Circuit has affirmed a lower court ruling on the invalidity of two Loma Linda University Medical Center patents.
The decision is a victory for Ion Beam Applications (IBA) of Louvain-la-Neuve, Belgium. The nuclear medicine products firm said the court decision will allow it to market proton-beam therapy systems in the U.S. that include gantry patient treatment rooms with or without fixed-beam patient treatment rooms.
IBA also will continue to market its control system that verifies the authenticity of proton-beam request signals before the beam is transported for treatment.
By AuntMinnie.com staff writers
November 17, 2006
Related Reading
IBA inks SAIC-Frederick deal, debuts new radionuclides, October 2, 2006
IBA shows financial gains in Q2, September 18, 2006
IBA to deliver cyclotron facility to Turkey, August 29, 2006
IBA launches synthesizer, new corporate look, June 7, 2006
Eastern Isotopes changes identity, April 21, 2006
Copyright © 2006 AuntMinnie.com
